Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 6 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2023 Filed Dec 13, 2023 22:11 UTC |
Zanganeh MahkamDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,000 | $2.07 | $10,350.00 |
DisclosureSEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · nonDerivative · entry 2 Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,814 F2 · shares: The Reporting Person purchased these shares in a single transaction on the open market. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:11 UTC |
Zanganeh MahkamDirector · Chief Executive Officer
|
OtherWarrant (right to buy) · Derivative | 315,681 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · derivative · entry 5 Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee Disclosed balance after: 0 Underlying: Common Stock · 315,681 shares Expires 2029-12-24 F1 · shares: The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:11 UTC |
Zanganeh MahkamDirector · Chief Executive Officer
|
OtherWarrant (right to buy) · Derivative | 489,814 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · derivative · entry 4 Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 489,814 shares Expires 2025-06-30 F1 · shares: The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:11 UTC |
Zanganeh MahkamDirector · Chief Executive Officer
|
OtherCommon Stock | 315,681 | $1.58 | $498,775.98 |
DisclosureSEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · nonDerivative · entry 3 Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee Disclosed balance after: 24,889,479 F1 · shares: The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants. F3 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:11 UTC |
Zanganeh MahkamDirector · Chief Executive Officer
|
OtherCommon Stock | 489,814 | $1.44 | $705,332.16 |
DisclosureSEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · nonDerivative · entry 1 Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 489,814 F1 · shares: The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 20:08 UTC |
Zanganeh MahkamDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 11,988,198 | Not disclosed Strike: $1.68 | Not disclosed |
DisclosureSEC source: 0001599298-23-000090 · wk-form4_1697486896.xml · derivative · entry 1 Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,988,198 Underlying: Common Stock · 11,988,198 shares Expires 2033-10-13 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on October 13, 2023. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on October 13, 2024. Note this does not include an additional 11,988,198 options which were granted on October 13, 2023 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 20:06 UTC |
Soni Manmeet SinghDirector · Chief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 14,000,000 | Not disclosed Strike: $1.68 | Not disclosed |
DisclosureSEC source: 0001569769-23-000007 · wk-form4_1697486782.xml · derivative · entry 2 Soni Manmeet Singh · CIK 0001569769 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000,000 Underlying: Common Stock · 14,000,000 shares Expires 2033-10-13 F3 · price: Not applicable. F2 · derivative.exercise_date: The option was granted on October 13, 2023. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on October 13, 2024. Note this does not include an additional 14,000,000 options which were granted on October 13, 2023 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 20:06 UTC |
Soni Manmeet SinghDirector · Chief Operating Officer
|
PurchaseCommon Stock | 2,976,190 | $1.68 | $4,999,999.20 |
DisclosureSEC source: 0001569769-23-000007 · wk-form4_1697486782.xml · nonDerivative · entry 1 Soni Manmeet Singh · CIK 0001569769 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,976,190 F1 · shares: The Issuer entered into a securities purchase agreement with the Reporting Person, pursuant to which the Issuer agreed to issue and sell to the Reporting Person shares of the Issuer's Common Stock at a per share purchase price equal to $1.68. F1 · balance_after: The Issuer entered into a securities purchase agreement with the Reporting Person, pursuant to which the Issuer agreed to issue and sell to the Reporting Person shares of the Issuer's Common Stock at a per share purchase price equal to $1.68. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 02:31 UTC |
Zanganeh MahkamDirector · Co-Chief Executive Officer
|
PurchaseCommon Stock | 6,748,629 | $1.05 | $7,086,060.45 |
DisclosureSEC source: 0001599298-23-000028 · wf-form4_167832905731524.xml · nonDerivative · entry 3 Zanganeh Mahkam · CIK 0001507650 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee. Disclosed balance after: 9,884,095 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 02:31 UTC |
Zanganeh MahkamDirector · Co-Chief Executive Officer
|
PurchaseCommon Stock | 804,672 | $1.05 | $844,905.60 |
DisclosureSEC source: 0001599298-23-000028 · wf-form4_167832905731524.xml · nonDerivative · entry 2 Zanganeh Mahkam · CIK 0001507650 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee. Disclosed balance after: 1,178,529 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 02:31 UTC |
Zanganeh MahkamDirector · Co-Chief Executive Officer
|
PurchaseCommon Stock | 15,973,743 | $1.05 | $16,772,430.15 |
DisclosureSEC source: 0001599298-23-000028 · wf-form4_167832905731524.xml · nonDerivative · entry 1 Zanganeh Mahkam · CIK 0001507650 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,395,269 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. Read SEC document |
| March 08, 2023 Filed Mar 13, 2023 22:27 UTC Amendment |
Zanganeh MahkamDirector · Co-CEO & President
|
PurchaseCommon Stock | 6,748,629 | $1.05 | $7,086,060.45 |
DisclosureSEC source: 0001387131-23-003381 · zangeneh-form4a_030823.xml · nonDerivative · entry 2 Zanganeh Mahkam · CIK 0001507650 · Director · Co-CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee. Disclosed balance after: 9,884,095 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. F3 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 08, 2023 Filed Mar 13, 2023 22:27 UTC Amendment |
Zanganeh MahkamDirector · Co-CEO & President
|
PurchaseCommon Stock | 16,778,415 | $1.05 | $17,617,335.75 |
DisclosureSEC source: 0001387131-23-003381 · zangeneh-form4a_030823.xml · nonDerivative · entry 1 Zanganeh Mahkam · CIK 0001507650 · Director · Co-CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee. Disclosed balance after: 24,573,798 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. F2 · shares: Includes the number of shares of Common Stock that were inadvertently previously disclosed as being held by Dr. Zanganeh personally, which are held by the Mahkam Zanganeh Revocable Trust. Dr. Zanganeh does not directly hold any shares personally, all of her shares are held through the Mahkam Zanganeh Revocable Trust. F3 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 22:24 UTC |
Dhingra AnkurChief Financial Officer
|
PurchaseCommon Stock | 196,362 | $1.05 | $206,180.10 |
DisclosureSEC source: 0001849682-23-000004 · wf-form4_167831424008442.xml · nonDerivative · entry 2 Dhingra Ankur · CIK 0001849682 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Dhingra Family Revocable Trust Disclosed balance after: 234,558 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 07, 2023 Filed Feb 14, 2024 21:35 UTC |
Xia YuDirector
|
PurchaseCommon Stock | 21,523,530 | $1.05 | $22,599,706.50 |
DisclosureSEC source: 0001999371-24-002333 · ownership.xml · nonDerivative · entry 1 Xia Yu · CIK 0001963544 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Akeso, Inc. Disclosed balance after: 21,523,530 F1 · balance_after: 21,523,530 shares of the Issuer's Common Stock were acquired on March 7, 2023 through a rights offering. F3 · ownership.nature: Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:12 UTC |
DUGGAN ROBERT WDirector · Chief Executive Officer
|
PurchaseCommon Stock | 376,489,880 | $1.05 | $395,314,374.00 |
DisclosureSEC source: 0001839882-23-006255 · dugganform4_030623.xml · nonDerivative · entry 1 DUGGAN ROBERT W · CIK 0001055919 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 552,354,161 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. Read SEC document |
| January 17, 2023 Filed Feb 14, 2024 21:35 UTC |
Xia YuDirector
|
PurchaseCommon Stock | 10,000,000 | $2.51 | $25,100,000.00 |
DisclosureSEC source: 0001999371-24-002333 · ownership.xml · nonDerivative · entry 2 Xia Yu · CIK 0001963544 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Akeso, Inc. Disclosed balance after: 10,000,000 F2 · balance_after: 10,000,000 shares of the Issuer's Common Stock were issued on January 17, 2023 in connection with the Collaboration and License Agreement with Akeso, Inc.("Akeso") pursuant to which the Issuer issued Akeso such shares. F3 · ownership.nature: Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:21 UTC |
Booth Robert F.Director
|
GrantStock Option (right to buy) · Derivative | 32,700 | $1.67 Strike: $5.00 | $54,609.00 |
DisclosureSEC source: 0001507567-23-000003 · wf-form4_167295366118350.xml · derivative · entry 2 Booth Robert F. · CIK 0001507567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,700 Underlying: Common Stock · 32,700 shares Expires 2033-01-03 F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $54,500. F3 · derivative.exercise_date: The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:21 UTC |
Booth Robert F.Director
|
GrantStock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001507567-23-000003 · wf-form4_167295366118350.xml · derivative · entry 1 Booth Robert F. · CIK 0001507567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-01-03 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:12 UTC |
Clark Kenneth ADirector
|
GrantStock Option (right to buy) · Derivative | 44,400 | $1.67 Strike: $5.00 | $74,148.00 |
DisclosureSEC source: 0001599298-23-000004 · wf-form4_167295314354996.xml · derivative · entry 2 Clark Kenneth A · CIK 0001561736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,400 Underlying: Common Stock · 44,400 shares Expires 2033-01-03 F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $74,000. F3 · derivative.exercise_date: The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:12 UTC |
Clark Kenneth ADirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001599298-23-000004 · wf-form4_167295314354996.xml · derivative · entry 1 Clark Kenneth A · CIK 0001561736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-01-03 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:09 UTC |
Soni Manmeet SinghDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001569769-23-000004 · wf-form4_167295295731969.xml · derivative · entry 1 Soni Manmeet Singh · CIK 0001569769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-01-03 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:17 UTC |
Cesano AlessandraDirector
|
GrantStock Option (right to buy) · Derivative | 16,350 | $1.67 Strike: $5.00 | $27,304.50 |
DisclosureSEC source: 0001827015-23-000003 · wf-form4_167295342532705.xml · derivative · entry 2 Cesano Alessandra · CIK 0001827015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,350 Underlying: Common Stock · 16,350 shares Expires 2033-01-03 F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $27,250. F3 · derivative.exercise_date: The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:17 UTC |
Cesano AlessandraDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001827015-23-000003 · wf-form4_167295342532705.xml · derivative · entry 1 Cesano Alessandra · CIK 0001827015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-01-03 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:14 UTC |
Mahatme UjwalaDirector
|
GrantStock Option (right to buy) · Derivative | 40,500 | $1.67 Strike: $5.00 | $67,635.00 |
DisclosureSEC source: 0001599298-23-000006 · wf-form4_167295328081339.xml · derivative · entry 2 Mahatme Ujwala · CIK 0001823894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,500 Underlying: Common Stock · 40,500 shares Expires 2033-01-03 F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $67,500. F3 · derivative.exercise_date: The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:14 UTC |
Mahatme UjwalaDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001599298-23-000006 · wf-form4_167295328081339.xml · derivative · entry 1 Mahatme Ujwala · CIK 0001823894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-01-03 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 23:28 UTC |
DUGGAN ROBERT WDirector · Chief Executive Officer
|
OtherCommon Stock | 9,346,434 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-012236 · duggan-form4_120622.xml · nonDerivative · entry 1 DUGGAN ROBERT W · CIK 0001055919 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,879,226 F1 · kind: 9,346,434 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Dr. Maky Zanganeh. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79. F1 · price: 9,346,434 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Dr. Maky Zanganeh. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79. Read SEC document |
| December 06, 2022 Filed Dec 9, 2022 23:22 UTC |
Zanganeh MahkamDirector · Co-CEO & President
|
OtherCommon Stock | 373,857 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-012291 · zangeneh-form4_120622.xml · nonDerivative · entry 1 Zanganeh Mahkam · CIK 0001507650 · Director · Co-CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,930,849 F1 · kind: 373,857 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Robert W. Duggan. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79. F1 · price: 373,857 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Robert W. Duggan. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:27 UTC |
Cesano AlessandraDirector
|
GrantStock Option (right to buy) · Derivative | 4,166 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001599298-22-000127 · wf-form4_166872044673174.xml · derivative · entry 2 Cesano Alessandra · CIK 0001827015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,166 Underlying: Common Stock · 4,166 shares Expires 2032-11-15 F2 · price: Not applicable. F3 · derivative.exercise_date: The option was granted on November 15, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:27 UTC |
Cesano AlessandraDirector
|
GrantStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001599298-22-000127 · wf-form4_166872044673174.xml · derivative · entry 1 Cesano Alessandra · CIK 0001827015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-11-15 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on November 15, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 15, 2023. Read SEC document |
| September 28, 2022 Filed Oct 3, 2022 16:50 UTC |
Booth Robert F.Director
|
GrantStock Option (right to buy) · Derivative | 6,250 | Not disclosed Strike: $1.21 | Not disclosed |
DisclosureSEC source: 0001839882-22-022703 · booth-form4_093022.xml · derivative · entry 2 Booth Robert F. · CIK 0001507567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,250 Underlying: Common Stock · 6,250 shares Expires 2032-09-28 F3 · price: Not applicable. F2 · derivative.exercise_date: The option was granted on September 28, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022. Read SEC document |
| September 28, 2022 Filed Oct 3, 2022 16:50 UTC |
Booth Robert F.Director
|
GrantStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $1.21 | Not disclosed |
DisclosureSEC source: 0001839882-22-022703 · booth-form4_093022.xml · derivative · entry 1 Booth Robert F. · CIK 0001507567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-09-28 F3 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on September 28, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on September 28, 2023. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:49 UTC |
Dhingra AnkurChief Financial Officer
|
PurchaseCommon Stock | 24,658 | $0.97 | $23,918.26 |
DisclosureSEC source: 0001599298-22-000102 · wf-form4_166076931714249.xml · nonDerivative · entry 2 Dhingra Ankur · CIK 0001849682 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Dhingra Family Revocable Trust Disclosed balance after: 38,196 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:49 UTC |
Dhingra AnkurChief Financial Officer
|
PurchaseCommon Stock | 11,557 | $0.97 | $11,210.29 |
DisclosureSEC source: 0001599298-22-000102 · wf-form4_166076931714249.xml · nonDerivative · entry 1 Dhingra Ankur · CIK 0001849682 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,057 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:38 UTC |
DUGGAN ROBERT WDirector · Chief Executive Officer
|
PurchaseCommon Stock | 94,849,203 | $0.97 | $92,003,726.91 |
DisclosureSEC source: 0001387131-22-008888 · duggan-form4_081622.xml · nonDerivative · entry 1 DUGGAN ROBERT W · CIK 0001055919 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,532,792 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:36 UTC |
Zanganeh MahkamDirector · Co-CEO & President
|
PurchaseCommon Stock | 1,030,925 | $0.97 | $999,997.25 |
DisclosureSEC source: 0001387131-22-008886 · zangeneh-form4_081622.xml · nonDerivative · entry 3 Zanganeh Maky · CIK 0001507650 · Director · Co-CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee. Disclosed balance after: 3,135,466 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:36 UTC |
Zanganeh MahkamDirector · Co-CEO & President
|
PurchaseCommon Stock | 4,593,777 | $0.97 | $4,455,963.69 |
DisclosureSEC source: 0001387131-22-008886 · zangeneh-form4_081622.xml · nonDerivative · entry 2 Zanganeh Maky · CIK 0001507650 · Director · Co-CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee. Disclosed balance after: 7,061,557 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:36 UTC |
Zanganeh MahkamDirector · Co-CEO & President
|
PurchaseCommon Stock | 184,430 | $0.97 | $178,897.10 |
DisclosureSEC source: 0001387131-22-008886 · zangeneh-form4_081622.xml · nonDerivative · entry 1 Zanganeh Maky · CIK 0001507650 · Director · Co-CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,969 F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. Read SEC document |
| August 16, 2022 Filed Mar 8, 2023 21:58 UTC Amendment |
Dhingra AnkurChief Financial Officer
|
PurchaseCommon Stock | 24,658 | $0.97 | $23,918.26 |
DisclosureSEC source: 0001849682-23-000002 · wf-form4a_167831269908577.xml · nonDerivative · entry 2 Dhingra Ankur · CIK 0001849682 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Dhingra Family Revocable Trust Disclosed balance after: 38,196 F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 16, 2022 Filed Mar 8, 2023 21:58 UTC Amendment |
Dhingra AnkurChief Financial Officer
|
PurchaseCommon Stock | 13,027 | $0.97 | $12,636.19 |
DisclosureSEC source: 0001849682-23-000002 · wf-form4a_167831269908577.xml · nonDerivative · entry 1 Dhingra Ankur · CIK 0001849682 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,527 F1 · shares: This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing. F1 · balance_after: This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 21:29 UTC |
Dhingra AnkurChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 600,000 | Not disclosed Strike: $1.33 | Not disclosed |
DisclosureSEC source: 0001849682-22-000003 · wf-form4_165420535405545.xml · derivative · entry 1 Dhingra Ankur · CIK 0001849682 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2032-05-31 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on May 31, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on May 31, 2023 (the one-year anniversary of the grant date). Read SEC document |
| May 23, 2022 Filed May 26, 2022 00:45 UTC |
DUGGAN ROBERT WDirector · Chief Executive Officer
|
OtherCommon Stock | 21,135 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-064838 · tm2216975-1_4seq1.xml · nonDerivative · entry 1 DUGGAN ROBERT W · CIK 0001055919 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,683,589 F1 · kind: The shares of Common Stock were collateral for a loan made by the Reporting Person to a third party, and were transferred to the Reporting Person in full satisfaction of the loan. F1 · price: The shares of Common Stock were collateral for a loan made by the Reporting Person to a third party, and were transferred to the Reporting Person in full satisfaction of the loan. Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 16:36 UTC |
Gayko UrteDirector
|
GrantStock Option (right to buy) · Derivative | 400,000 | Not disclosed Strike: $1.93 | Not disclosed |
DisclosureSEC source: 0001599298-22-000034 · wf-form4_165100539719830.xml · derivative · entry 1 Gayko Urte · CIK 0001559217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2032-04-25 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on April 25, 2022. The shares underlying the option are scheduled to vest in four equal annual installments over four years. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:07 UTC |
Gayko UrteDirector
|
GrantStock Option (right to buy) · Derivative | 42,553 | $1.13 Strike: $2.82 | $48,084.89 |
DisclosureSEC source: 0001599298-22-000008 · wf-form4_164141681907145.xml · derivative · entry 2 Gayko Urte · CIK 0001559217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,553 Underlying: Common Stock · 42,553 shares Expires 2032-01-03 F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $48,000. F3 · derivative.exercise_date: The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:07 UTC |
Gayko UrteDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $2.82 | Not disclosed |
DisclosureSEC source: 0001599298-22-000008 · wf-form4_164141681907145.xml · derivative · entry 1 Gayko Urte · CIK 0001559217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-01-03 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:01 UTC |
Clark Kenneth ADirector
|
GrantStock Option (right to buy) · Derivative | 58,510 | $1.13 Strike: $2.82 | $66,116.30 |
DisclosureSEC source: 0001599298-22-000005 · wf-form4_164141648612518.xml · derivative · entry 2 Clark Kenneth A · CIK 0001561736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,510 Underlying: Common Stock · 58,510 shares Expires 2032-01-03 F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $66,000. F3 · derivative.exercise_date: The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:01 UTC |
Clark Kenneth ADirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $2.82 | Not disclosed |
DisclosureSEC source: 0001599298-22-000005 · wf-form4_164141648612518.xml · derivative · entry 1 Clark Kenneth A · CIK 0001561736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-01-03 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:03 UTC |
Soni Manmeet SinghDirector
|
GrantStock Option (right to buy) · Derivative | 82,446 | $1.13 Strike: $2.82 | $93,163.98 |
DisclosureSEC source: 0001599298-22-000006 · wf-form4_164141659851379.xml · derivative · entry 2 Soni Manmeet Singh · CIK 0001569769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,446 Underlying: Common Stock · 82,446 shares Expires 2032-01-03 F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $93,000. F3 · derivative.exercise_date: The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:03 UTC |
Soni Manmeet SinghDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $2.82 | Not disclosed |
DisclosureSEC source: 0001599298-22-000006 · wf-form4_164141659851379.xml · derivative · entry 1 Soni Manmeet Singh · CIK 0001569769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-01-03 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC |
Mahatme UjwalaDirector
|
GrantStock Option (right to buy) · Derivative | 47,872 | $1.13 Strike: $2.82 | $54,095.36 |
DisclosureSEC source: 0001599298-22-000007 · wf-form4_164141670774490.xml · derivative · entry 2 Mahatme Ujwala · CIK 0001823894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,872 Underlying: Common Stock · 47,872 shares Expires 2032-01-03 F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $54,000. F3 · derivative.exercise_date: The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.